Apalutamide Active in Castration - Resistant Prostate Cancer

Apalutamide prolongs metastasis - free survival in non - metastatic castration - resistant prostate cancer
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, Pharmacy, Urology, Conference News, Source Type: news

Related Links:

Treatment for prostate cancer with external beam radiotherapy was found to be associated with an increased risk for development of bladder cancer when compared with radical prostatectomy.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news
Publication date: December 2018Source: Journal of Photochemistry and Photobiology B: Biology, Volume 189Author(s): Abhijit Mukherjee, Suvranil Ghosh, Rudraditya Sarkar, Satyajit Samanta, Sudipta Ghosh, Mahadeb Pal, Adinath Majee, Sukanta Kumar Sen, Bula SinghAbstractIn the progress of small molecule as drug candidates, 4-hydroxycoumarin based compounds bearing a crucial place as potent antibiotic agents with appreciable safety in drug invention. Being synthetically and easily obtainable, 4-hydroxycoumarin related compounds with planar structure have been promoted predominantly as DNA targeting agent. Nevertheless, here we ...
Source: Journal of Photochemistry and Photobiology B: Biology - Category: Speech-Language Pathology Source Type: research
ConclusionsBCR has an impact on survival, but this effect appears to be limited to a subgroup of patients with specific clinical risk factors. Short PSA-DT and a high final Gleason score after RP, and a short IBF after RT and a high biopsy Gleason score are the main factors that have a negative impact on survival. These factors may form the basis of new BCR risk stratification (European Association of Urology BCR Risk Groups), which needs to be validated formally.Patient summaryThis review looks at the risk of death in men who shows rising prostate-specific antigen (PSA) in the blood test performed after curative surgery o...
Source: European Urology - Category: Urology & Nephrology Source Type: research
ConclusionsAvailable models predicting LNI are characterized by suboptimal accuracy and clinical net benefit for patients diagnosed via MRI-targeted biopsies. A novel nomogram including mpMRI and MRI-targeted biopsy data should be used to identify candidates for ePLND in this setting.Patient summaryWe developed the first nomogram to predict lymph node invasion (LNI) in prostate cancer patients diagnosed via magnetic resonance imaging-targeted biopsy undergoing radical prostatectomy. Adoption of this model to identify candidates for extended pelvic lymph node dissection could avoid up to 60% of these procedures at the cost ...
Source: European Urology - Category: Urology & Nephrology Source Type: research
ConclusionsDisparities for black men can both motivate and disincentivize participation depending upon a positive or negative view of research. Confusion over prostate cancer clinical care has fueled some mistrust among black men affecting both clinical care and research participation. With increased education, health literacy, and assurances of research integrity and transparency, black men may be more willing to participate in prostate cancer testing and research.Supplement informationThis article is part of a supplement entitled African American Men's Health: Research, Practice, and Policy Implications, which is sponsor...
Source: American Journal of Preventive Medicine - Category: International Medicine & Public Health Source Type: research
April Doyle, a single mom from Visalia, Cal., only lets herself look three months into her future. Since she was first diagnosed with breast cancer in 2014, she’s tried a new treatment every three months to keep the cancer from spreading from her breast tissue to other parts of her body. But it returned: this time in her bone. She is almost out of options for her hard-to-treat cancer, but she finds comfort in online support groups where other women with metastatic breast cancer share their experiences. “Eventually we know we will exhaust all of our options until they keep coming up with more treatments,” ...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Cancer healthytime Source Type: news
PROSTATE cancer symptoms don ’t always appear in the early stages until the tumour has grown and put pressure on other parts of the body. When this happens, pain in certain parts of the body may begin to show.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
CONCLUSIONSBased on the current Medicare Physician Fee Schedule, HRS is cost-effective at a willingness to pay threshold of $100,000. These results contain substantial uncertainty, suggesting more evidence is needed to refine future decision making.
Source: Practical Radiation Oncology - Category: Cancer & Oncology Source Type: research
PROSTATE cancer symptoms don ’t always appear in the early stages until the tumour has grown and put pressure on other parts of the body. When this happens, pain in certain parts of the body may begin to show.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
(Natural News) If you are one of the 2.9 million men in the U.S. with prostate cancer, you might feel powerless about your situation. As the second leading cause of cancer deaths in America, it’s quite understandable to be worried. However, too much stress can hurt your chances of survival, so why not focus your...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
More News: Cancer | Cancer & Oncology | Conferences | Prostate Cancer | Urology & Nephrology